4 ms·
Isn't this one of those very few cases were nationalisation of a company is called for?
by johansch 11y ago
Isn't this one of those very few cases were nationalisation of a company is called for?
- nickff 11y agoWhy do poor business decisions make a case for nationalization?
- infamouscow 11y agoBecause we've agreed that the public can't hunt these people down and kill them for this kind of nonsense.
- nickff 11y agoI have re-read your comment a dozen times, trying to grasp what you mean, and come up short each time. Do you mean to say that whenever a business makes a decision that you disagree with, you (or someone else) should feel morally entitled to go a kill the individuals working there? Or do you mean that whenever a business makes a decision that you disagree with, the state is entitled to focibly take the company? I personally find both to be morally problematic (to say the least), and unless you can establish a viewpoint neutral rule for this new criteria for nationalization (or murder), it will be enforced arbitrarily and capriciously.
- supercanuck 11y ago>I have re-read your comment a dozen times, trying to grasp what you mean, and come up short each time Keep trying, don't give up
- zem 11y agowould you complain about the state simply setting up a plant to manufacture and distribute a generic version of the drug, thereby driving the predatory company out of business? that seems like it would be an ideal solution that doesn't involve forcibly taking anything away from anyone.
- nickff 11y agoI would have no moral objections to an alternative producer being set up (by the government or anyone else), so long as nobody is forced to buy from either one. There may be some practical issues (such as the regulator being a member of the same organization as the regulated producer), or issues with the scope (and scope creep) of the project, but those are only related issues.
- elektromekatron 11y agoSo you could be in favor of nationalisation, by way of making it common property, of the IP that supports his business, but not nationalisation of the business itself.
- nickff 11y agoThe IP that supports the business is already common property. As far as I understand it, the outrage here stems from exactly this fact, that the IP is common property, but they dramatically increased the prices. I am not sure what the reaction would have been if this was a patent-protected drug. Presumably the patent exists to allow for this type of dramatic price change (; though I do not support the current patent system).
- elektromekatron 11y agoI understand that they have currently secured a de-facto exclusive distribution right for the US market from the FDA. Ok, it isn't classic IP, but it has the same effect and as far as I understand it is transferable property, as otherwise this company would not have been able to acquire the rights in this way.
- eimai134 11y agoCheck out the book The Sociopath Next Door - it talks about how there are so many sociopathic people today because societies used to conveniently do away with them. I'd guess this is similar to what the person is referring to.
- johansch 11y agoI have re-read your comment a dozen times, trying to grasp what you mean, and come up short each time. Are you a sociopath?
- nickff 11y agoI am trying to understand what the case for nationalization is in this instance. Is it an arbitrary emotional standard, or a rational viewpoint-neutral standard? I am wary of emotional and viewpoint-dependent standards. Please also review the Hacker News Guidelines.[1] >Be civil. Don't say things you wouldn't say in a face-to-face conversation. Avoid gratuitous negativity. When disagreeing, please reply to the argument instead of calling names. E.g. "That is idiotic; 1 + 1 is 2, not 3" can be shortened to "1 + 1 is 2, not 3." [1] https://news.ycombinator.com/newsguidelines.html https://news.ycombinator.com/newsguidelines.html
- thescriptkiddie 11y agoPrice gouging on life-saving pharmaceuticals is not a poor business decision. It's an excellent business decision. But it is also a crime against humanity.
- anigbrowl 11y agoWhen a private actor is exploiting a flaw in the regulatory system, it might be easier to fix that flow or strengthen other parts of the regulatory system (eg perhaps there are remedies in antitrust law), rather than impinging on a property interest because we don't like the outcome. Here the problem is that other manufacturers can't take up making these drugs at a sensible price because they have to get FDA approval for their copies, and doing that requires test comparisons with the original drug which you propose to copy to ensure that they behave identically. So either we need to change that requirement to a different testing approach (eg proving your copy is good through chemical assay rather than in a clinical trial) or by making licensing contingent on cooperation with regulatory priorities (so if you want to sell your off-patent drug, you have to make samples available to would-be competitors or provide the FDA with samples on request and at cost).
- pdeuchler 11y agoThat's like using a nuclear bomb to clear out an ant problem